Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-I Hsu

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Oncotarget|December 22, 2017
Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resectionWei-Chi Sun, I-Shu Chen, Huei-Lung Liang, et al.
The American Journal of Gastroenterology|February 28, 2007
Helicobacter pylori infection and the risk of gastric malignancyPing-I Hsu, Kwok-Hung Lai, Ping-Ning Hsu, et al.
Helicobacter|June 14, 2018
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and ActinobacteriaPing-I Hsu, Chao-Yu Pan, John Y Kao, et al.
Journal of the Chinese Medical Association : JCMA|March 23, 2005
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinomaChi-Pin Lin, Hsien-Chung Yu, Jin-Shiung Cheng, et al.
Journal of the Chinese Medical Association : JCMA|November 24, 2020
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trialZhi-Fu Tseng, Ping-I Hsu, Nan-Jing Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2025
Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagusSung-Shuo Kao, Deng-Chyan Wu, Seng-Kee Chuah, et al.
Gastrointestinal Endoscopy|May 3, 2006
Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcersChing-Chu Lo, Ping-I Hsu, Gin-Ho Lo, et al.
Anticancer Research|April 4, 2008
Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesionsPing-I Hsu, Pei-Jung Lu, E-Ming Wang, et al.
Oncology|October 28, 2024
Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort StudyLi-Fu Kuo, Wen-Chun Liu, Ming-Feng Li, et al.
Diabetology & Metabolic Syndrome|June 10, 2026
Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin-niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectivesYi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi-Jing Tsai, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Oncotarget|December 22, 2017
Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resectionWei-Chi Sun, I-Shu Chen, Huei-Lung Liang, et al.
The American Journal of Gastroenterology|February 28, 2007
Helicobacter pylori infection and the risk of gastric malignancyPing-I Hsu, Kwok-Hung Lai, Ping-Ning Hsu, et al.
Helicobacter|June 14, 2018
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and ActinobacteriaPing-I Hsu, Chao-Yu Pan, John Y Kao, et al.
Journal of the Chinese Medical Association : JCMA|March 23, 2005
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinomaChi-Pin Lin, Hsien-Chung Yu, Jin-Shiung Cheng, et al.
Journal of the Chinese Medical Association : JCMA|November 24, 2020
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trialZhi-Fu Tseng, Ping-I Hsu, Nan-Jing Peng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2025
Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagusSung-Shuo Kao, Deng-Chyan Wu, Seng-Kee Chuah, et al.
Gastrointestinal Endoscopy|May 3, 2006
Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcersChing-Chu Lo, Ping-I Hsu, Gin-Ho Lo, et al.
Anticancer Research|April 4, 2008
Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesionsPing-I Hsu, Pei-Jung Lu, E-Ming Wang, et al.
Oncology|October 28, 2024
Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort StudyLi-Fu Kuo, Wen-Chun Liu, Ming-Feng Li, et al.
Diabetology & Metabolic Syndrome|June 10, 2026
Real-world comparative outcomes of atorvastatin, rosuvastatin, and lovastatin-niacin fixed-dose combination in metabolic dysfunction-associated steatotic liver disease: hepatic, metabolic, and economic perspectivesYi Tseng Tsai, Sriyani Padmalatha Konara Mudiyanselage, Yi-Jing Tsai, et al.
Pageof 21